N/A N=354 Full Automaticity and Remote Follow-up
Tachyarrhythmia
Primary: Remote Follow-up as an Alternative to Onsite Visit — 203 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=80 Trial of Realignment Therapy for Treatment of Medial Knee Osteoarthritis
Knee Osteoarthritis
Primary: Mean Change WOMAC Pain Scale (Most Symptomatic Treated Knee) — -2.2; -1.7 units on a scale change from baseline
Phase 3 N=344 Staccato Loxapine in Agitated Patients With Schizophrenia
Patients With Schizophrenia and Acute Agitation
Primary: Change in PANSS-EC From Baseline — -5.5; -8.1; -8.6 units on a scale — p=0.0004
Phase 2 N=31 Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC
Carcinoma, Non-Small-Cell Lung
Primary: Objective Tumor Response Rate — 1 Participants
N/A N=31 Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses
Cataract · Presbyopia · Corneal Astigmatism
Primary: Mean Percent Reduction in Cylinder — 60.94 percent change
Phase 4 N=21 Omega-3 Supplementation to ADHD Medication in Children
Attention Deficit Hyperactivity Disorder · Deficient Emotional Self-Regulation
Primary: Emotional Control Subscale of the Behavior Rating Inventory of Executive Function - Parent Form (BRIEF-Parent) — 65.3; 58.4 units on a scale
N/A N=60 The Prostate Immobilization Device Study
Adenocarcinoma of the Prostate
Primary: Deviation of the Prostate Rectal Interface From Its Position at Time of Simulation. — .319; .095 CENTIMETERS
Phase 2 N=55 Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies
Adult Nasal Type Extranodal NK/T-cell Lymphoma · Anaplastic Large Cell Lymphoma · Angioimmunoblastic T-cell Lymphoma
Primary: Ability to Successfully Deliver the Investigational Therapy Without Incurring the Protocol Suspension Rules — 51 Participants
Phase 4 N=60 Oxytocin And Uterotonic Agent Use For Cesarean Delivery
Uterine Atony · Hypotension
Primary: 1. Amount of Oxytocin to Obtain Satisfactory Uterine Tone. — 8.4; 4.0 IU
Phase 4 N=140 Effect of Testosterone in Men With Erectile Dysfunction
Erectile Dysfunction · Testosterone Deficiency · Diabetes
Primary: Change From Baseline in Erectile Function Domain Score of the International Index of Erectile Function (IIEF) — 19.6; 20.1; 21.3; 21.3 units on a scale
Phase 3 N=242 Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Renal Function · Endothelial Function · Blood Pressure
Primary: Change in Renal Plasma Flow (RPF) in Response to Captopril in High Sodium Balance [Vitamin D] — 35.7; 35.9 mL/min per 1.73 m^2 — p=0.72
Phase 3 N=68 A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
Schizophrenia
Primary: Mean Change From Baseline at Final Assessment in Positive and Negative Syndrome Scale (PANSS) Total Score — -7.9 units on a scale
N/A N=6 Safety of Spine Radiofrequency Procedures
Radiofrequency Ablation in Patients With Spinal Hardware
Primary: Number of Procedures in Which Temperature of Screws Increased — 4; 2 procedures
Phase 3 N=38 Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis
Polycystic Ovary Syndrome · Disorder of Glucose Regulation
Primary: Glucose Metabolism — 3; 6; 10 Participants — p=.007
Phase 2 N=113 Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia
Leukemia · Acute Disease · Acute Myeloid Leukemia
Primary: Remission Rate Defined as the Percentage of Patients Whose Respnse is CR or CRp Based on International Working Group (IWG) Response Criteria and Treatment Outcomes…